Cleared Abbreviated

ENDO TOOL GLUCOSE MANAGEMENT SYSTEM (EGMS) (K132547) - FDA 510(k) Clearance

Class II General Hospital device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2014
Decision
247d
Days
Class 2
Risk

K132547 is an FDA 510(k) clearance for the ENDO TOOL GLUCOSE MANAGEMENT SYSTEM (EGMS). Classified as Calculator, Drug Dose (product code NDC), Class II - Special Controls.

Submitted by Monarch Medical Technologies (Silver Spring, US). The FDA issued a Cleared decision on April 17, 2014 after a review of 247 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 868.1890 - the FDA general hospital device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Monarch Medical Technologies devices

Submission Details

510(k) Number K132547 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 13, 2013
Decision Date April 17, 2014
Days to Decision 247 days
Submission Type Abbreviated
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
118d slower than avg
Panel avg: 129d · This submission: 247d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code NDC Calculator, Drug Dose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - NDC Calculator, Drug Dose

All 25
Devices cleared under the same product code (NDC) and FDA review panel - the closest regulatory comparables to K132547.
EndoTool SubQ
K180366 · Al Pacheco and Associates · Sep 2018
InPen Dose Calculator
K181327 · Companion Medical, Inc. · Jul 2018
Glooko Mobile Insulin Dosing System
K171450 · Glooko, Inc. · Feb 2018
ACCU-CHEK ADVISOR INSULIN GUIDANCE SOFTWARE
K043529 · Roche Diagnostics Corp. · Apr 2005
ABBOTT PHARAMACOKINETICS SYSTEMS
K851573 · Abbott Laboratories · Jan 1986